These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19651688)

  • 1. Philippines joins other developing countries in limiting prices of drugs.
    Bland B
    BMJ; 2009 Aug; 339():b3151. PubMed ID: 19651688
    [No Abstract]   [Full Text] [Related]  

  • 2. Are rich nations up for drug reform?
    Check E
    Nature; 2006 May; 441(7090):135. PubMed ID: 16688137
    [No Abstract]   [Full Text] [Related]  

  • 3. Paying a high price for low costs: why there should be no legal constraints on the profits that can be made on drugs for tropical diseases.
    Sonderholm J
    J Med Ethics; 2009 May; 35(5):315-9. PubMed ID: 19407038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. South Africa's moral victory.
    Lancet; 2001 Apr; 357(9265):1303. PubMed ID: 11343727
    [No Abstract]   [Full Text] [Related]  

  • 5. EU agrees deal on cheaper drugs for developing world.
    Watson R
    BMJ; 2003 Jun; 326(7401):1229. PubMed ID: 12791716
    [No Abstract]   [Full Text] [Related]  

  • 6. [How are prices for important drugs stipulated in poor countries?].
    Lien L
    Tidsskr Nor Laegeforen; 2003 Apr; 123(7):958-9. PubMed ID: 12737074
    [No Abstract]   [Full Text] [Related]  

  • 7. More drugs, less protection.
    Nature; 2002 Sep; 419(6904):233. PubMed ID: 12239521
    [No Abstract]   [Full Text] [Related]  

  • 8. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices.
    Moken MC
    Am J Law Med; 2003; 29(4):525-42. PubMed ID: 15119247
    [No Abstract]   [Full Text] [Related]  

  • 9. TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
    Sykes AO
    Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299
    [No Abstract]   [Full Text] [Related]  

  • 10. Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.
    Buckely M
    Seton Hall Law Rev; 2011; 41(2):625-69. PubMed ID: 21739760
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-35. PubMed ID: 22423396
    [No Abstract]   [Full Text] [Related]  

  • 12. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 13. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
    Curti AM
    Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical Research and Manufacturers of America v. Walsh: the Supreme Court allows the states to proceed with expanding access to drugs.
    Jost TS
    Yale J Health Policy Law Ethics; 2004; 4(1):69-84. PubMed ID: 15052860
    [No Abstract]   [Full Text] [Related]  

  • 15. Questions raised about whether compulsory licenses get best prices.
    Owens B
    Nat Med; 2015 Apr; 21(4):300. PubMed ID: 25849264
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Health Policy Tracking Service, A Service of Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-21. PubMed ID: 21374837
    [No Abstract]   [Full Text] [Related]  

  • 17. The level of income appears to have no consistent bearing on pharmaceutical prices across countries.
    Morel CM; McGuire A; Mossialos E
    Health Aff (Millwood); 2011 Aug; 30(8):1545-52. PubMed ID: 21821572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Link cost to clinical outcome.
    Norris J
    BMJ; 2007 May; 334(7601):968. PubMed ID: 17493992
    [No Abstract]   [Full Text] [Related]  

  • 19. Rx: higher prices.
    Kosterlitz J
    Natl J (Wash); 1993 Feb; 25(7):396-9. PubMed ID: 10125572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. At what price?
    Danzon PM
    Nature; 2007 Sep; 449(7159):176-9. PubMed ID: 17851515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.